Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Breast (Edinburgh, Scotland)|February 29, 2024
2023 Year in review: Early breast cancerGuilherme Nader-Marta, Ann H PartridgeCurrent Opinion in Oncology|August 8, 2023
Circulating tumor DNA in breast cancer: a biomarker for patient selectionElisa Agostinetto, Guilherme Nader-Marta, Michail IgnatiadisAutopsy & Case Reports|October 21, 2015
Immune thrombocytopenia and autoimmune thyroid disease: a controversial overlapGuilherme Nader Marta, Fernando Peixoto Ferraz de CamposExpert Opinion on Drug Metabolism & Toxicology|January 12, 2024
Pharmacokinetics and pharmacodynamics of antibody-drug conjugates for the treatment of patients with breast cancerFrançois Cherifi, Angélique Da Silva, Diogo Martins-Branco, et al.Journal of Medical Case Reports|July 18, 2016
Near-drowning-associated pneumonia with bacteremia caused by coinfection with methicillin-susceptible Staphylococcus aureus and Edwardsiella tarda in a healthy white man: a case reportLucas Santos Zambon, Guilherme Nader Marta, Natan Chehter, et al.European Journal of Clinical Investigation|March 4, 2021
CDK4/6 and PI3K inhibitors: A new promise for patients with HER2-positive breast cancerElisa Agostinetto, Véronique Debien, Guilherme Nader Marta, et al.Clinics (Sao Paulo, Brazil)|January 27, 2021
Efficacy and safety of sorafenib in elderly patients with advanced hepatocellular carcinomaGuilherme Nader Marta, Leonardo G da Fonseca, Maria Ignez Braghiroli, et al.Therapeutic Advances in Medical Oncology|July 12, 2023
Antibody-drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatmentGuilherme Nader-Marta, Chiara Molinelli, Véronique Debien, et al.Ecancermedicalscience|April 18, 2018
Cystic brain metastases in ALK-rearranged non-small cell lung cancerGuilherme Nader Marta, Renata Rodrigues da Cunha Colombo Bonadio, Renata Eiras Martins, et al.European Journal of Cancer (Oxford, England : 1990)|October 19, 2023
Ki-67 index after neoadjuvant endocrine therapy as a prognostic biomarker in patients with ER-positive/HER2-negative early breast cancer: a systematic review and meta-analysisDiogo Martins-Branco, Guilherme Nader-Marta, Chiara Molinelli, et al.Pageof 4